LifeStance Health Group, Inc. (LFST) revealed Loss for full year of -$57.443 million
The company's earnings totaled -$57.443 million, or -$0.15 per share. This compares with -$186.262 million, or -$0.51 per share, last year.
The company's revenue for the period rose 18.6% to $1.251 billion from $1.055 billion last year.
LifeStance Health Group, Inc. earnings at a glance (GAAP) :
-Earnings: -$57.443 Mln. vs. -$186.262 Mln. last year.-EPS: -$0.15 vs. -$0.51 last year.-Revenue: $1.251 Bln vs. $1.055 Bln last year.
Looking ahead, LifeStance Health Group expects a rise in first quarter and annual revenue.
For the first-quarter of 2025, the company expects adjusted EBITDA of $27 to $33 million, with revenue of $320 to $340 million.
For the first-quarter of 2024, the Group had recorded adjusted EBITDA of $27.7 million, on revenue of $300.4 million.
For the full-year 2025, the Group projects adjusted EBITDA of $130 to $150 million, with revenue of $1.40 to $1.44 billion.
For the full-year 2024, the company had recorded adjusted EBITDA of $119.7 million, on revenue of $1.251 billion.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.